Overview


According to FutureWise analysis, the market for Heterocyclic and Fluoro Organic Compounds is expected to grow with a CAGR of 22.50% over the forecast period 2023-2031, and reach a market value of US$ 14.3 billion by 2031.

Immune cell engineering is a field of biotechnology and medical research that focuses on modifying immune cells to enhance their innate abilities to recognize and combat diseases, particularly cancer and certain autoimmune disorders. This is achieved through genetic or biochemical alterations that augment the immune system's responses. There are several approaches to immune cell engineering, including CAR-T Cell Therapy or Chimeric Antigen Receptor T-cell therapy (CAR-T), which involves modifying a patient's T cells to express a synthetic receptor (CAR) that targets a specific protein on the surface of cancer cells. This enables the T cells to recognize and attack cancer cells more effectively. Furthermore, Natural Killer (NK) cells are immune cells that recognize and kill cancer cells. Also, Dendritic cells present antigens (molecules associated with foreign substances) to T cells, activating the immune response.

Immune cell engineering has emerged as a transformative field of various applications. In the realm of research, it has revolutionized our understanding of the immune system and its intricate interactions with pathogens, tumors, and other physiological processes. Using techniques like CRISPR-Cas9, scientists can precisely manipulate immune cells to study their responses, uncover novel pathways, and develop targeted therapies. However, the most promising breakthroughs in immune cell engineering lie in the domains of cell therapy and regenerative medicine. By harnessing the power of engineered immune cells, we have witnessed unprecedented advancements in treating a spectrum of diseases, including cancer, autoimmune disorders, and genetic conditions. Engineered T-cells, for instance, have shown remarkable success in eradicating cancer cells by enhancing the body's natural defenses. This heralds a new era in personalized medicine, where therapies can be tailored to individual patients based on their genetic and immunological profiles.

FutureWise Market Research has published a report that provides an insightful analysis immune cell engineering market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts immune cell engineering market estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Thermo Fisher Scientific
  • Merck KGaA
  • Danaher Corporation
  • Lonza Group
  • Miltenyi Biotec
  • Takara Bio Group
  • CellGenix GmbH
  • FUJIFILM Irvine Scientific
  • Agilent Technologies
  • Bio-Techne Corporation
  • Bio-Rad Laboratories
  • BD
  • Charles River Laboratories
  • Creative Bioarray
  • Sartorius AG
  • Novogene Corporation
  • AGC Biologics
  • Catalent
  • WuXi AppTec
  • ReachBio LLC

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent Developments in Immune Cell Engineering Market:

  • In 2021, Merck launched a new Beacon optogenetics platform, which uses light and genetically modified proteins to precisely control cell function. This enabled more advanced immune cell engineering for neurological research.

The increasing prevalence of chronic disorders, including cancer and autoimmune disorders, has increased the demand for personalized and precisely targeted immunotherapies. These therapies hinge on the fundamental principles of immune cell engineering, offering a revolutionary approach to treating these conditions. By tailoring treatments to individual patients' specific immune profiles, immune cell engineering promises heightened efficacy and reduced side effects, addressing a critical need in modern healthcare. This increased demand is a primary driver propelling the growth of the immune cell engineering market. Additionally, the continuous progress in genetic engineering techniques has ushered in a new era of precision in modifying and manipulating immune cells. These advancements allow scientists and researchers to fine-tune the genetic makeup of immune cells with remarkable accuracy, enhancing their effectiveness in combating diseases. This level of precision is crucial in developing tailored immunotherapies that may target specific conditions or individual patients. As these technologies continue to evolve, they expand the possibilities for innovative treatments and bolster the economic viability and attractiveness of the immune cell engineering market, driving its remarkable growth trajectory. Also, the ongoing research and innovation in gene editing technologies and delivery systems hold immense potential for revolutionizing the immune cell engineering market. As scientists delve deeper into genetic manipulation's intricacies, they uncover new avenues to enhance the precision, efficiency, and safety of immune cell modifications. The constant evolution of these technologies keeps the immune cell engineering field vibrant and opens up exciting opportunities for companies to discover innovative solutions in this rapidly expanding market. However, the major restrain posed by stringent regulatory frameworks and approval processes represents a significant hurdle for aspiring entrants into the immune cell engineering market. Navigating through the complexity of regulations and satisfying the rigorous criteria set forth by regulatory bodies demands substantial time, resources, and expertise. Also, scaling up production for mass-market adoption is a formidable task, as it entails intricate manufacturing processes and rigorous quality control measures. This complexity not only necessitates substantial investments but also prolongs the time to market, potentially deterring new players and hindering the rapid expansion of the immune cell engineering market.

By Cell Type

  • T Cells
  • NK Cells
  • Dendritic Cells
  • Tumor Cells
  • Stem Cells
  • Others

By Product

  • Consumables
  • Instruments
  • Software

By Application

  • Research Applications
  • Cell Therapy & Regenerative Medicine
  • Others

By End User

  • Pharmaceutical & Biotechnology Companies
  • Research Institutes
  • Cell Banks
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. Due to rising investments in cell-based research and advancements in gene-editing technologies, the rising prevalence of chronic diseases like cancer, autoimmune disorders, and cardiovascular diseases, and increasing cancer research in the region will likely drive market expansion. Additionally, technological advancements in cell engineering and the high adoption of immunotherapies further foster the target market. Also, the presence of leading biopharma companies and product launches are factors increasing the demand for the immune cell engineering market in the region. For instance, in April 2022, Thermo Fisher Scientific launched a new Gibco CTS DynaCellect Electroporation System for more consistent and efficient delivery of molecules into hard-to-transfect cells. This improved cell engineering workflow efficiency in cell line development and cell therapy manufacturing.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Immune Cell Engineering Market By Cell Type, By Product, By Application, By End User, and By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape, mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.  Market Introduction
    •   1. Objectives of the Study 
        2. Market Definition 
        3. Market Scope 
           3.1. Years Considered for the Study
           3.2. Market Covered
        4. Currency 
        5. Limitations 
        6. Stakeholders 

  • 2.  Research Methodology
    •   1. Research Data 
           1.1. Secondary Data
              1.1.1. Key Data from Secondary Sources
           1.2 Primary Data
              1.2.1. Key Data from Primary Sources
        3. Market Size Estimation 
        4. Market Breakdown and Data Triangulation 
        5. Assumptions for the Study 

  • 3.  Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights

  • 4.  Immune Cell Engineering Market Variables, Trends & Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Application Overview
        6. Regulatory Framework
           6.1. Reimbursement Framework
           6.2. Standards and Compliances

  • 5.  Market Overview
    •   1. Market Dynamics
           1.1. Market Driver Analysis
              1.1.1. Increasing focus of Immune Cell Engineering Market Companies on Brand Protection
              1.1.2. Untapped Opportunities in Emerging Regions
           1.2. Market Restraint Analysis
              1.2.1. High Cost Associated with Implementation of Predictive Analysis
           1.3. Industry Challenges
              1.3.1. Presence of Ambiguous Regulatory Framework

  • 6.  Immune Cell Engineering Market Analysis Tools
    •   1. Industry Analysis - Porter’s
           1.1. Supplier Power
           1.2. Buyer Power
           1.3. Substitution Threat
           1.4. Threat from New Entrants
           1.5. Competitive Rivalry
        2. Pestel Analysis
           2.1. Political Landscape
           2.2. Environmental Landscape
           2.3. Social Landscape
           2.4. Application Landscape
           2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
           3.1. Joint Ventures
           3.2. Mergers and Acquisitions
           3.3. Licensing and Partnership
           3.4. Application Collaborations
           3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies

  • 7.  Immune Cell Engineering Market, By Cell Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. T Cells
        2. NK Cells
        3. Dendritic Cells
        4. Tumor Cells
        5. Stem Cells
        6. Others

  • 8.  Immune Cell Engineering Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Consumables
        2. Instruments
        3. Software

  • 9.  Immune Cell Engineering Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Research Applications
        2. Cell Therapy & Regenerative Medicine
        3. Others

  • 10.  Immune Cell Engineering Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Pharmaceutical & Biotechnology Companies
        2. Research Institutes
        3. Cell Banks
        4. Others

  • 11.  North America Immune Cell Engineering Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
           2.1. U.S.A
           2.2. Canada
           2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.  Latin America Immune Cell Engineering Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
           2.1. Brazil
           2.2. Venezuela
           2.3. Argentina
           2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.  Europe Immune Cell Engineering Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
           2.1. Germany
           2.2. U.K
           2.3. France
           2.4. Italy
           2.5. Spain
           2.6. Russia
           2.7. Poland
           2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.  Asia Pacific Immune Cell Engineering Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
           2.1. Japan
           2.2. China
           2.3. India
           2.4. Australia and New Zealand
           2.5. ASEAN
           2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031  

  • 15.  Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
           2.1. GCC
           2.2. Israel
           2.3. South Africa
           2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.  Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix

  • 17.  Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Thermo Fisher Scientific
           1.1. Company Overview
           1.2. Product Portfolio
           1.3. SWOT Analysis
           1.4. Financial Overview
           1.5. Strategic Overview
        2. Merck KGaA
           2.1. Company Overview
           2.2. Product Portfolio
           2.3. SWOT Analysis
           2.4. Financial Overview
           2.5. Strategic Overview
        3. Danaher Corporation
           3.1. Company Overview
           3.2. Product Portfolio
           3.3. SWOT Analysis
           3.4. Financial Overview
           3.5. Strategic Overview
        4. Lonza Group
           4.1. Company Overview
           4.2. Product Portfolio
           4.3. SWOT Analysis
           4.4. Financial Overview
           4.5. Strategic Overview
        5. Miltenyi Biotec
           5.1. Company Overview
           5.2. Product Portfolio
           5.3. SWOT Analysis
           5.4. Financial Overview
           5.5. Strategic Overview
        6. Takara Bio Group
           6.1. Company Overview
           6.2. Product Portfolio
           6.3. SWOT Analysis
           6.4. Financial Overview
           6.5. Strategic Overview
        7. CellGenix GmbH
           7.1. Company Overview
           7.2. Product Portfolio
           7.3. SWOT Analysis
           7.4. Financial Overview
           7.5. Strategic Overview
        8. FUJIFILM Irvine Scientific
           8.1. Company Overview
           8.2. Product Portfolio
           8.3. SWOT Analysis
           8.4. Financial Overview
           8.5. Strategic Overview
        9. Agilent Technologies
           9.1. Company Overview
           9.2. Product Portfolio
           9.3. SWOT Analysis
           9.4. Financial Overview
           9.5. Strategic Overview
        10. Bio-Techne Corporation
           10.1. Company Overview
           10.2. Product Portfolio
           10.3. SWOT Analysis
           10.4. Financial Overview
           10.5. Strategic Overview
        11. Bio-Rad Laboratories
           11.1. Company Overview
           11.2. Product Portfolio
           11.3. SWOT Analysis
           11.4. Financial Overview
           11.5. Strategic Overview
        12. BD
           12.1. Company Overview
           12.2. Product Portfolio
           12.3. SWOT Analysis
           12.4. Financial Overview
           12.5. Strategic Overview
        13. Charles River Laboratories
           13.1. Company Overview
           13.2. Product Portfolio
           13.3. SWOT Analysis
           13.4. Financial Overview
           13.5. Strategic Overview
        14. Creative Bioarray
           14.1. Company Overview
           14.2. Product Portfolio
           14.3. SWOT Analysis
           14.4. Financial Overview
           14.5. Strategic Overview
        15. Sartorius AG
           15.1. Company Overview
           15.2. Product Portfolio
           15.3. SWOT Analysis
           15.4. Financial Overview
           15.5. Strategic Overview
        16. Novogene Corporation
           16.1. Company Overview
           16.2. Product Portfolio
           16.3. SWOT Analysis
           16.4. Financial Overview
           16.5. Strategic Overview
        17. AGC Biologics
           17.1. Company Overview
           17.2. Product Portfolio
           17.3. SWOT Analysis
           17.4. Financial Overview
           17.5. Strategic Overview
        18. Catalent
           18.1. Company Overview
           18.2. Product Portfolio
           18.3. SWOT Analysis
           18.4. Financial Overview
           18.5. Strategic Overview
        19. WuXi AppTec
           19.1. Company Overview
           19.2. Product Portfolio
           19.3. SWOT Analysis
           19.4. Financial Overview
           19.5. Strategic Overview
        20. ReachBio LLC
           20.1. Company Overview
           20.2. Product Portfolio
           20.3. SWOT Analysis
           20.4. Financial Overview
           20.5. Strategic Overview

  • 18.  Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated
      by administrations
        5. The overall economic slowdown of the developing and developed nations

  • 19.  FutureWise SME Key Takeaway Points for Client
    •    

Partner

Our Clients